Skip to main content
. 2022 Aug 30;10:1004739. doi: 10.3389/fped.2022.1004739

Table 1.

Summary of the variables in the association analysis including the amount of data available for each variable.

Variable of interest Definition Available data for children 0–59 months of age, n = 1,096 N (%)a
Outcome variable
Need for respiratory support Treatment with invasive or non-invasive positive pressure ventilation during RSV hospitalization 1,075 (98.1%) Yes = 202(19%)
Hospitalization > 72 h Length of stay measured in hours and dichotomized as stay under 72 h or above 72 h. 978 (89.2%) >72 h = 317 (28.9%)
Demographic risk factors
Age In months, by age group 1,096 (100%) <3 m = 301 (27%)
3–5 m = 181 (17%)
6–11 m = 170 (16%)
12–23 m = 297 (27%)
24–59 m = 147 (13%)
Sex Biological sex, male or female 1,096 (100%) Male = 615 (56%)
Siblings Children <18 years of age, living in the same household 1,031 (94%) Yes = 766 (74%)
Pets Daily contact with pet animals 1,032 (94%) Yes = 259 (25%)
Day-care attendance Attending nursery-home etc. 822 (75%) Yes = 493 (60%)
Gestational risk factors
Maternal age Maternal age at time of delivery 1,091 (99.5%) Mean = 31.0 (SD 4.90)
Smoking during pregnancy Smoking any time during pregnancy 974 (88.8%) Yes = 32(3%)
Born before peak season Being born before peak of first RSV season, applies to children <6 months of age n.a.
Prematurity Gestational age <32 weeks 1,090 (99%) Yes = 29 (3%)
Cesarean delivery Cesarean delivery, planned or acute 1,091 (99.5%) Yes = 222 (20%)
Multiple gestation Twins or triplets 1,096 (100%) Yes = 56 (5%)
Small for gestational age Birth weight Z-score < −1.28 SD according to sex and gestational age 1,090 (99%) Yes = 87 (8%)
Comorbidity and dispositions
No breastfeeding Never breastfeed 739 (67.4%) Yes = 46 (6%)
Family history of atopy History of asthma or atopic disease in first order relatives 738 (67.3%) Yes = 125 (17%)
Comorbidity Including trisomy 21, neuromuscular impairment, congenital heart disease, pulmonary disease, BPD, immunodeficiency, and cancer. Conditions identified by ICD-10 codes provided in supp. data 1,096 (100%) Yes = 94 (9%)
Respiratory support during neonatal period Treatment with invasive or non-invasive positive pressure ventilation during neonatal period. Not including treatment for RSV disease 1,096 (100%) Yes = 84 (8%)
Viral Co-detection Influenza A and B virus, Parainfluenza virus subtype 1-3 and Human metapneumovirus 1,019 (93%) Yes = 76 (7%)

aNumber of positive outcomes for each variable, and N-positive as percentage of the available data.